Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

And the HBA packaging winners are...

This article was originally published in The Rose Sheet

Executive Summary

Diesel Green by Marbert wins HBA Global Expo International Package Design Grand Award, as well as Limited Distribution Fragrance award in New York City Oct. 14. Mass distribution fragrance winner was Mary Kay's Velocity, and mass distribution skin care winner was Reflect.com. Cosmetics category winner was Chanel's Artist Palette; Additional winners include Futuresse by Biodroga for skin care (limited distribution) and PureOlogy Serious Colour Care by Pureology for personal care. Packaging awards were selected by 30 judges from leading marketing companies, HBA says. Individuals honored were: Estee Lauder Senior VP Roger Caracappa for Packaging Executive of the Year; Revlon ExecVP Neil Scancarella for Lifetime Achievement in Product Development; and Procter & Gamble Cosmetic team Lee Ellen Drechsler, Tom Rabe and Ed Smith for New Product Technical Team...

You may also be interested in...



US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010678

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel